BEX2 and glioblastoma: In our study, TQ treatment of A172 glioblastoma cells with 25 and 50 μM concentrations for 48 hours significantly up-regulated two candidate tumor suppressor genes: Sprouty RTJ Signaling Antagonist 4 (SPRY4) and Brain Expressed X-Linked 2 (BEX2).